PAGEInsider
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 23 '26 | Sale | 8.18 | 1,341 | 10,969 | 102,356 | Mar 25 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 16 '26 | Sale | 8.00 | 3,235 | 25,880 | 103,697 | Mar 17 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 24 '25 | Sale | 6.94 | 1,349 | 9,364 | 84,087 | Mar 26 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 17 '25 | Sale | 6.29 | 2,092 | 13,162 | 85,436 | Mar 18 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 10 '25 | Sale | 4.88 | 1,583 | 7,724 | 78,528 | Mar 11 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 '25 | Option Exercise | 0.00 | 2,667 | 0 | 80,111 | Mar 11 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 25 '24 | Sale | 17.54 | 1,367 | 23,980 | 77,444 | Mar 26 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 15 '24 | Sale | 15.43 | 1,312 | 20,247 | 73,061 | Mar 19 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 11 '24 | Sale | 16.35 | 1,418 | 23,188 | 74,373 | Mar 19 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 '24 | Option Exercise | 0.00 | 2,666 | 0 | 75,791 | Mar 19 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Sep 12 '23 | Option Exercise | 12.79 | 1,000 | 12,790 | 73,125 | Sep 13 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 15 '23 | Sale | 20.79 | 1,362 | 28,316 | 61,670 | Mar 17 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 13 '23 | Sale | 20.14 | 1,476 | 29,727 | 63,032 | Mar 13 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 '23 | Option Exercise | 0.00 | 2,667 | 0 | 64,508 | Mar 13 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 '22 | Sale | 31.05 | 1,410 | 43,781 | 51,386 | Mar 11 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 '22 | Option Exercise | 0.00 | 2,667 | 0 | 8,000 | Mar 11 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Aug 11 '21 | Sale | 58.45 | 80,146 | 4,684,472 | 50,129 | Aug 13 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Aug 11 '21 | Option Exercise | 7.95 | 94,202 | 748,866 | 130,275 | Aug 13 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 10 '21 | Option Exercise | 2.84 | 30,404 | 86,320 | 49,404 | Mar 11 |
| CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 10 '21 | Sale | 55.13 | 13,331 | 734,934 | 36,073 | Mar 11 |